The former group director of virology at Bristol-Myers Squibb in Wallingford, Connecticut, Robert Hindes, MD, co-founded Trek Therapeutics in September 2014. As the organization’s chief medical officer, Robert Hindes, MD, is responsible for the development of clinical strategy.

1. Trek Therapeutics' Work as a Public-
Benefit Corporation
Robert Hindes MD

2. Introduction
 The former group director of virology at Bristol-Myers
Squibb in Wallingford, Connecticut, Robert Hindes,
MD, co-founded Trek Therapeutics in September
2014. As the organization’s chief medical officer,
Robert Hindes, MD, is responsible for the
development of clinical strategy.
As a public-benefit corporation, Trek Therapeutics is
a for-profit organization that places as much
emphasis on serving the public as it does on the
traditional goal of corporations to generate a profit
for shareholders. In Trek’s case, the mission is to
develop medicines that treat infectious diseases and
making them accessible and affordable to the global
population.

3. Trek Therapeutics
 Trek notes that millions of people die each year of
treatable and preventable conditions. The company
places specific focus on hepatitis C (HCV), which
affects between 130 and 170 million people
worldwide. Many of these people do not have access
to the highly effective treatments available for the
condition because of the high prices associated with
them, especially in the developing world. Trek serves
the public by developing effective, accessible HCV
treatments.